Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Depreciation & Amortization (CF) of $18.3 million for Q1 2026, down 0.65% year-over-year from $18.4 million in Q1 2025, and down 10.96% quarter-over-quarter from $20.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $18.3 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 0.65% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $73.4 million (up 7.68% YoY), while the FY2025 annual figure was $73.5 million, up 11.14% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $18.3 million, down from $20.5 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $21.9 million in Q1 2023, with the low at $7.3 million in Q2 2023.
- The 5-year median for Depreciation & Amortization (CF) is $16.4 million (2024), against an average of $14.9 million.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) surged 121.22% in 2023, then declined 25.35% in 2024.
- Ascend Wellness Holdings' Depreciation & Amortization (CF) stood at $11.3 million in 2022, then surged by 31.1% to $14.8 million in 2023, then increased by 18.1% to $17.5 million in 2024, then climbed by 17.52% to $20.5 million in 2025, then retreated by 10.96% to $18.3 million in 2026.
- Business Quant data shows AAWH's Depreciation & Amortization (CF) at $18.3 million in Q1 2026, $20.5 million in Q4 2025, and $16.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 21.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.05 Mn |
| Jun 30, 2026 | 21.05 Mn |
| Mar 31, 2026 | 18.28 Mn |
| Mar 31, 2026 | 18.28 Mn |
| Dec 31, 2025 | 20.53 Mn |
| Dec 31, 2025 | 20.53 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Jun 30, 2025 | 17.83 Mn |
| Mar 31, 2025 | 18.40 Mn |
| Mar 31, 2025 | 18.40 Mn |
| Dec 31, 2024 | 17.47 Mn |
| Dec 31, 2024 | 17.47 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Jun 30, 2024 | 15.68 Mn |
| Jun 30, 2024 | 15.68 Mn |
| Mar 31, 2024 | 16.38 Mn |
| Mar 31, 2024 | 16.38 Mn |